Dallah Healthcare Company

SASE:4004 Rapporto sulle azioni

Cap. di mercato: ر.س15.2b

Dallah Healthcare Crescita futura

Future criteri di controllo 2/6

Dallah Healthcare prevede che gli utili e i ricavi cresceranno rispettivamente di 14.2% e 12.7% all'anno. Si prevede che l'EPS crescerà di 11.7% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 17.2% in 3 anni.

Informazioni chiave

14.2%

Tasso di crescita degli utili

11.7%

Tasso di crescita dell'EPS

Healthcare crescita degli utili14.8%
Tasso di crescita dei ricavi12.7%
Rendimento futuro del capitale proprio17.2%
Copertura analitica

Good

Ultimo aggiornamento22 Jan 2025

Aggiornamenti recenti sulla crescita futura

Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 14
Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Recent updates

Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist

Jan 08
Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist

With EPS Growth And More, Dallah Healthcare (TADAWUL:4004) Makes An Interesting Case

Dec 21
With EPS Growth And More, Dallah Healthcare (TADAWUL:4004) Makes An Interesting Case

Some Shareholders Feeling Restless Over Dallah Healthcare Company's (TADAWUL:4004) P/E Ratio

Oct 31
Some Shareholders Feeling Restless Over Dallah Healthcare Company's (TADAWUL:4004) P/E Ratio

The Return Trends At Dallah Healthcare (TADAWUL:4004) Look Promising

Oct 07
The Return Trends At Dallah Healthcare (TADAWUL:4004) Look Promising

Do Dallah Healthcare's (TADAWUL:4004) Earnings Warrant Your Attention?

Sep 19
Do Dallah Healthcare's (TADAWUL:4004) Earnings Warrant Your Attention?

Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 14
Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

The Price Is Right For Dallah Healthcare Company (TADAWUL:4004)

Jul 18
The Price Is Right For Dallah Healthcare Company (TADAWUL:4004)

Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist

May 30
Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist

We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Apr 16
We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E

Mar 18
What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E

Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes

Feb 25
Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes

Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward

Oct 30
Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward

Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return

Jul 26
Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return

Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)

Apr 17
Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)

Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Feb 06
Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends

Dec 05
Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends

We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Nov 01
We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)

Aug 28
Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)

Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger

Aug 12
Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger

Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Jul 28
Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%

May 26
Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%

Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)

May 20
Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)

Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Apr 16
Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Feb 03
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Jan 10
Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Oct 19
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Jul 09
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically

Jun 16
Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically

Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher

May 02
Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher

What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?

Mar 17
What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?

Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?

Mar 02
Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?

Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year

Feb 15
Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year

Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?

Feb 01
Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?

Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 05
Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price

Dec 22
Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price

Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?

Nov 20
Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?

Previsioni di crescita degli utili e dei ricavi

SASE:4004 - Stime future degli analisti e dati finanziari passati (SAR Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/20275,0587908791,0863
12/31/20264,2176295809277
12/31/20253,8315353327397
12/31/20243,3244942966585
9/30/20243,203471358779N/A
6/30/20243,105444326667N/A
3/31/20243,010385415724N/A
12/31/20232,943360329626N/A
9/30/20232,831325348562N/A
6/30/20232,682270369549N/A
3/31/20232,595286333519N/A
12/31/20222,488274267442N/A
9/30/20222,370305214367N/A
6/30/20222,313311122260N/A
3/31/20222,220289166290N/A
12/31/20212,105259246362N/A
9/30/20211,935202178305N/A
6/30/20211,742206240363N/A
3/31/20211,498165110215N/A
12/31/20201,31813254183N/A
9/30/20201,25715082211N/A
6/30/20201,20712335198N/A
3/31/20201,24613133244N/A
12/31/20191,252147106307N/A
9/30/20191,22711088290N/A
6/30/20191,20611543264N/A
3/31/20191,1931195255N/A
12/31/20181,181142-51204N/A
9/30/20181,189172-158184N/A
6/30/20181,203217N/A253N/A
3/31/20181,218268N/A297N/A
12/31/20171,212295N/A353N/A
9/30/20171,202284N/A457N/A
6/30/20171,180268N/A387N/A
3/31/20171,181252N/A382N/A
12/31/20161,163225N/A343N/A
9/30/20161,122228N/A244N/A
6/30/20161,073194N/A261N/A
3/31/20161,030175N/A233N/A
12/31/2015985165N/A214N/A
9/30/2015948161N/A204N/A
6/30/2015917156N/A168N/A
3/31/2015892154N/A151N/A
12/31/2014859147N/A149N/A
9/30/2014831149N/A137N/A
6/30/2014805149N/A138N/A
3/31/2014773138N/A108N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di 4004 ( 14.2% all'anno) è inferiore al tasso di risparmio ( 14.7% ).

Guadagni vs Mercato: Si prevede che gli utili di 4004 ( 14.2% all'anno) cresceranno più rapidamente del mercato SA ( 5.9% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di 4004 cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di 4004 ( 12.7% all'anno) crescerà più rapidamente del mercato SA ( -0.5% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di 4004 ( 12.7% all'anno) crescerà più lentamente di 20% all'anno.


Previsioni di crescita dell'utile per azione


Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di 4004 sarà basso tra 3 anni ( 17.2 %).


Scoprire le aziende in crescita

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2025/02/06 13:18
Prezzo dell'azione a fine giornata2025/02/06 00:00
Guadagni2024/09/30
Guadagni annuali2023/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Dallah Healthcare Company è coperta da 22 analisti. 7 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Ibrahim ElaiwatAljazira Capital Company
Jassim Al-JubranAljazira Capital Company
Rim Ben Salah GharbiAlphaMena